Technical Analysis for MDP - Medexus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
B 2.800 -0.71% -0.020
MDP closed down 0.71 percent on Tuesday, December 3, 2024, on 63 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Walk Strength -0.71%
Wide Bands Range Expansion -0.71%
Above Upper BB Strength -0.71%
Overbought Stochastic Strength -0.71%
Up 3 Days in a Row Strength -0.71%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medexus Pharmaceuticals Inc. Description

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.


Classification

Keywords: Health Healthcare Infrastructure Pipe Pharma Pipeline Pharmaceutical Integrated Disease Drugs Pharmaceuticals Diseases Arthritis Medication Immunosuppressants Rheumatoid Arthritis Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China

Is MDP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.16
52 Week Low 1.44
Average Volume 31,829
200-Day Moving Average 2.047
50-Day Moving Average 2.457
20-Day Moving Average 2.322
10-Day Moving Average 2.532
Average True Range 0.148
RSI (14) 67.11
ADX 33.25
+DI 35.137
-DI 17.151
Chandelier Exit (Long, 3 ATRs) 2.476
Chandelier Exit (Short, 3 ATRs) 2.154
Upper Bollinger Bands 2.874
Lower Bollinger Band 1.770
Percent B (%b) 0.93
BandWidth 47.571
MACD Line 0.097
MACD Signal Line 0.015
MACD Histogram 0.0825
Fundamentals Value
Market Cap 40.47 Million
Num Shares 14.5 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -4.26
Price-to-Sales 0.84
Price-to-Book 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.905
Resistance 3 (R3) 2.917 2.893 2.888
Resistance 2 (R2) 2.893 2.867 2.888 2.882
Resistance 1 (R1) 2.847 2.850 2.835 2.835 2.876
Pivot Point 2.823 2.823 2.818 2.818 2.823
Support 1 (S1) 2.777 2.797 2.765 2.765 2.724
Support 2 (S2) 2.753 2.780 2.748 2.718
Support 3 (S3) 2.707 2.753 2.713
Support 4 (S4) 2.695